Epoxomicin, CAS [[134381-21-8]]

Produktübersicht

• Artikelname: Epoxomicin, CAS [[134381-21-8]]
• Artikelnummer: BYT-ORB1300427
• Hersteller Artikelnummer: orb1300427
• Alternativnummer: BYT-ORB1300427-1, BYT-ORB1300427-5, BYT-ORB1300427-1, BYT-ORB1300427-10, BYT-ORB1300427-25, BYT-ORB1300427-50, BYT-ORB1300427-100, BYT-ORB1300427-500
• Hersteller: Biorbyt
• Kategorie: Biochemikalien
• Alternative Synonym: covalently, cytotoxicities, BBB, BU-4061T, Apoptosis, 20S proteasome, Epoxomicin, Epoxyketone-containing, Proteasome

Produktbeschreibung

Epoxomicin is a potent and selective proteasome inhibitor that primarily targets the chymotrypsin-like (CH-L) activity of the 20S proteasome. It is widely used in research to study proteasome function, protein degradation pathways, and has demonstrated anti-inflammatory and anti-cancer effects in both cellular and animal models.

Produkteigenschaften

• Molekulargewicht: 554.72
• Reinheit: 99.91% (May vary between batches)
• CAS Nummer: [134381-21-8]
• Formel: C28H50N4O7
• Target-Kategorie: Apoptosis,Proteasome

Anwendungsbeschreibung

• Anwendungsbeschreibung: Solubility: H2O:< 1 mg/mL (insoluble or slightly soluble),10% DMSO+40% PEG300+5% Tween 80+45% Saline:3.3 mg/mL (5.95 mM),DMSO:120 mg/mL (216.33 mM),Ethanol:93 mg/mL (167.65 mM)